SYRE icon

Spyre Therapeutics
SYRE

Overview Fund Trends Analyst Outlook Journalist POV

23 hedge funds and large institutions have $26.6M invested in Spyre Therapeutics in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.69M
2
+$6.61M
3
+$2.55M
4
RCM
RA Capital Management
Massachusetts
+$2.54M
5
BBA
Baker Bros. Advisors
New York
+$1.97M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$6.69M
2
$6.61M
3
$2.55M
4
$2.54M
5
$1.97M
6
$1.7M
7
$1.53M
8
$690K
9
$515K
10
$486K
11
$340K
12
$304K
13
$273K
14
$243K
15
$62K
16
$54K
17
$35K
18
$29K
19
$11K
20
$4K
21
$4K
22
$4K
23
$4K